0001562180-19-000490.txt : 20190124 0001562180-19-000490.hdr.sgml : 20190124 20190124172954 ACCESSION NUMBER: 0001562180-19-000490 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190122 FILED AS OF DATE: 20190124 DATE AS OF CHANGE: 20190124 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Barrett Elizabeth CENTRAL INDEX KEY: 0001757545 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36544 FILM NUMBER: 19540719 MAIL ADDRESS: STREET 1: C/O SAGE THERAPEUTICS, INC. STREET 2: 215 FIRST STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sage Therapeutics, Inc. CENTRAL INDEX KEY: 0001597553 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-299-8380 MAIL ADDRESS: STREET 1: 215 FIRST STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2019-01-22 false 0001597553 Sage Therapeutics, Inc. SAGE 0001757545 Barrett Elizabeth C/O SAGE THERAPEUTICS, INC. 215 FIRST STREET CAMBRIDGE MA 02142 true false false false Stock Options (Right to buy) 137.29 2019-01-22 4 A false 20000.00 0.00 A 2029-01-22 Common Stock 20000.00 20000.00 D All of the shares subject to the option vest in equal monthly installments during the 36 months following January 22, 2019 (the "Grant Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the third anniversary of the Grant Date, subject to the reporting person's continued service as a director of the issuer through such date. /s/ Jennifer Fitzpatrick, as Attorney-in-Fact for Elizabeth Barrett 2019-01-24